P. D. J. Vegt

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, P. A. Steerenberg et al. · Cancer Immunology Immunotherapy · 1992 · 201 citations · Full text

Medicine, Immunology, Urology +14

Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the Bladder

P. D. J. Vegt, J. Alfred Witjes, Wim P.J. Witjes et al. · The Journal of Urology · 1995 · 124 citations

Medicine, Oncology, Urology +13

Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin

Elizabeth C. de Boer, Wim H. de Jong, A.P.M. van der Meijden et al. · Cancer Immunology Immunotherapy · 1991 · 112 citations · Full text

Medicine, Immunology, Oncology +12

Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, A.P.M. van der Meijden et al. · Urological Research · 1991 · 102 citations

Medicine, Oncology, Urology +7

Does Isoniazid Reduce Side Effects of Intravesical Bacillus Calmette-Guerin Therapy in Superficial Bladder Cancer? Interim Results of European Organization for Research and Treatment of Cancer Protocol 30911

P. D. J. Vegt, Adrian P.M. van der Meijden, Richard Sylvester et al. · The Journal of Urology · 1997 · 92 citations

Medicine, Oncology, Pharmacology +7